Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Neurology

Neuro/Psych pharmacology

Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders

Journal of Affective Disorders | Nov 21, 2017 Neuro/Psych pharmacology

Risk of death associated with new benzodiazepine use among persons with Alzheimer's disease: A matched cohort study

International Journal of Geriatric Psychiatry | Nov 21, 2017 Neuro/Psych pharmacology

The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current anti-depressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study vs escitalopram

Journal of Affective Disorders | Nov 20, 2017 Neuro/Psych pharmacology

Electroconvulsive therapy and age: Age-related clinical features and effectiveness in treatment resistant major depressive episode

Journal of Affective Disorders | Nov 19, 2017 Neuro/Psych pharmacology

A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression

Journal of Affective Disorders | Nov 19, 2017 Neuro/Psych pharmacology

Effects of venlafaxine vs lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial

Psychiatry Research | Nov 19, 2017 Neuro/Psych pharmacology

The efficacy of istradefylline for treating mild wearing-off in Parkinson's disease

Clinical Neuropharmacology | Nov 19, 2017 Neuro/Psych pharmacology

Medical cannabis in Parkinson's disease: Real-life patients' experience

Clinical Neuropharmacology | Nov 19, 2017 Neuro/Psych pharmacology

Targeting pioglitazone hydrochloride therapy after stroke or transient ischemic attack according to pretreatment risk for stroke or myocardial infarction

JAMA Neurology | Nov 18, 2017 Neuro/Psych pharmacology

Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis

Schizophrenia Research | Nov 18, 2017 Neuro/Psych pharmacology

« Prev 1 … 56 57 58 59 60 … 72 Next »

Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders

Risk of death associated with new benzodiazepine use among persons with Alzheimer's disease: A matched cohort study

The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current anti-depressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study vs escitalopram

Electroconvulsive therapy and age: Age-related clinical features and effectiveness in treatment resistant major depressive episode

A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression

Effects of venlafaxine vs lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial

The efficacy of istradefylline for treating mild wearing-off in Parkinson's disease

Medical cannabis in Parkinson's disease: Real-life patients' experience

Targeting pioglitazone hydrochloride therapy after stroke or transient ischemic attack according to pretreatment risk for stroke or myocardial infarction

Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis

New Treatment in Uveitis

Optimising Caesarean Section Practices

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Environmental Pollution and Lifestyle Disorders: An Emerging Global Challenge

Tinnitus seems to be somehow connected to a crucial bodily function

Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders

Risk of death associated with new benzodiazepine use among persons with Alzheimer's disease: A matched cohort study

The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current anti-depressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study vs escitalopram

Electroconvulsive therapy and age: Age-related clinical features and effectiveness in treatment resistant major depressive episode

A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression

Effects of venlafaxine vs lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial

The efficacy of istradefylline for treating mild wearing-off in Parkinson's disease

Medical cannabis in Parkinson's disease: Real-life patients' experience

Targeting pioglitazone hydrochloride therapy after stroke or transient ischemic attack according to pretreatment risk for stroke or myocardial infarction

Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis

New Treatment in Uveitis

Optimising Caesarean Section Practices

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Environmental Pollution and Lifestyle Disorders: An Emerging Global Challenge

Tinnitus seems to be somehow connected to a crucial bodily function

Select Specialty

Select Topic